Follow
Pekka Taimen
Pekka Taimen
Institute of Biomedicine, University of Turku
No verified email
Title
Cited by
Cited by
Year
Nuclear lamins
T Dechat, SA Adam, P Taimen, T Shimi, RD Goldman
Cold Spring Harbor perspectives in biology 2 (11), a000547, 2010
4702010
A progeria mutation reveals functions for lamin A in nuclear assembly, architecture, and chromosome organization
P Taimen, K Pfleghaar, T Shimi, D Möller, K Ben-Harush, MR Erdos, ...
Proceedings of the National Academy of Sciences 106 (49), 20788-20793, 2009
2312009
Mutant p53–associated myosin-X upregulation promotes breast cancer invasion and metastasis
A Arjonen, R Kaukonen, E Mattila, P Rouhi, G Högnäs, H Sihto, BW Miller, ...
The Journal of clinical investigation 124 (3), 1069-1082, 2014
1742014
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: preliminary findings from a multi‐institutional study
SB Ginsburg, A Algohary, S Pahwa, V Gulani, L Ponsky, HJ Aronen, ...
Journal of Magnetic Resonance Imaging 46 (1), 184-193, 2017
1412017
Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: preliminary findings
R Shiradkar, S Ghose, I Jambor, P Taimen, O Ettala, AS Purysko, ...
Journal of Magnetic Resonance Imaging 48 (6), 1626-1636, 2018
1362018
Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization
J Toivonen, I Montoya Perez, P Movahedi, H Merisaari, M Pesola, ...
PloS one 14 (7), e0217702, 2019
1042019
Caspase-3 is required in the apoptotic disintegration of the nuclear matrix
K Kivinen, M Kallajoki, P Taimen
Experimental cell research 311 (1), 62-73, 2005
1002005
Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial)
I Jambor, PJ Boström, P Taimen, K Syvänen, E Kähkönen, M Kallajoki, ...
Journal of Magnetic Resonance Imaging 46 (4), 1089-1095, 2017
992017
Evaluation of different mathematical models for diffusion‐weighted imaging of normal prostate and prostate cancer using high b‐values: a repeatability study
I Jambor, H Merisaari, P Taimen, P Boström, H Minn, M Pesola, ...
Magnetic resonance in medicine 73 (5), 1988-1998, 2015
922015
Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension
M Li, S Vattulainen, J Aho, M Orcholski, V Rojas, K Yuan, M Helenius, ...
American journal of respiratory cell and molecular biology 50 (6), 1118-1128, 2014
852014
Mathematical models for diffusion‐weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of …
J Toivonen, H Merisaari, M Pesola, P Taimen, PJ Boström, T Pahikkala, ...
Magnetic resonance in medicine 74 (4), 1116-1124, 2015
832015
A prospective comparison of 18F-prostate-specific membrane antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with …
M Anttinen, O Ettala, S Malaspina, I Jambor, M Sandell, S Kajander, ...
European urology oncology 4 (4), 635-644, 2021
792021
Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction
H Merisaari, P Movahedi, IM Perez, J Toivonen, M Pesola, P Taimen, ...
Magnetic resonance in medicine 77 (3), 1249-1264, 2017
792017
Tumor-associated macrophages provide significant prognostic information in urothelial bladder cancer
MM Boström, H Irjala, T Mirtti, P Taimen, T Kauko, A Ålgars, S Jalkanen, ...
PloS one 10 (7), e0133552, 2015
772015
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
I Jambor, A Kuisma, E Kähkönen, J Kemppainen, H Merisaari, O Eskola, ...
European journal of nuclear medicine and molecular imaging 45, 355-364, 2018
732018
Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the …
UG Falagario, I Jambor, A Lantz, O Ettala, A Stabile, P Taimen, HJ Aronen, ...
European urology oncology 4 (6), 971-979, 2021
672021
Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy
I Jambor, E Kähkönen, P Taimen, H Merisaari, J Saunavaara, K Alanen, ...
Journal of Magnetic Resonance Imaging 41 (5), 1394-1404, 2015
612015
Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: a prospective multi-institutional trial
I Jambor, J Verho, O Ettala, J Knaapila, P Taimen, KT Syvänen, ...
PLoS medicine 16 (6), e1002813, 2019
602019
Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells
D Shah, L Virtanen, C Prajapati, M Kiamehr, J Gullmets, G West, ...
Cells 8 (6), 594, 2019
562019
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy
K Lahdensuo, A Erickson, I Saarinen, H Seikkula, J Lundin, M Lundin, ...
Modern Pathology 29 (12), 1565-1574, 2016
562016
The system can't perform the operation now. Try again later.
Articles 1–20